SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2,438.19 |
| Enterprise Value ($M) | 4,013.28 |
| Book Value ($M) | -893.92 |
| Book Value / Share | -11.66 |
| Price / Book | -2.73 |
| NCAV ($M) | -1,514.81 |
| NCAV / Share | -19.75 |
| Price / NCAV | -1.61 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.42 |
| Return on Assets (ROA) | -0.36 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.98 |
| Current Ratio | 2.03 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,168.74 |
| Assets | 1,789.63 |
| Liabilities | 2,683.55 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 937.82 |
| Operating Income | -349.40 |
| Net Income | -626.60 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -158.42 |
| Cash from Investing | -176.74 |
| Cash from Financing | 646.40 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Armistice Capital, Llc | 9.10 | ||
| 13G/A | Rtw Investments, Lp | 9.80 | 32.21 | |
| 13G/A | Vanguard Group Inc | 11.66 | 19.91 | |
| 13G/A | Wellington Management Group Llp | 13.01 | 32.11 | |
| 13G/A | State Street Corp | 6.14 | 93.22 | |
| 13G/A | Fmr Llc | 2.40 | -71.79 | |
| 13G/A | BlackRock Inc. | 10.20 | 15.48 | |
| 13G | Camber Capital Management LP |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 115,611 | 505,908 | 22.85 | |
| 57,972 | 398,098 | 14.56 | |
| 79,303 | 224,289 | 35.36 | |
| 101,925 | 992,559 | 10.27 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PRAX – Praxis Precision Medicines, Inc. | PRLD – Prelude Therapeutics Incorporated |
| PRTA – Prothena Corporation plc | PYXS – Pyxis Oncology, Inc. |
| QDEL – QuidelOrtho Corporation |
Financial data and stock pages provided by
Fintel.io